Cancer
86 results
1 - 86
Hereditary nonpolyposis colorectal cancer
Breast cancer BRCA1 and BRCA2 mutations
Carcinoembryonic antigen (CEA)
Renal scan (radionuclide) - GENITOURINARY
BRCA1 and BRCA2 genotyping
Magnetic resonance imaging (MRI) - PELVIS
MRI - BREAST
α-Fetoprotein (AFP)
Prostate-specific antigen
K-ras
Fecal occult blood tests
BENEFITS, COSTS AND RISKS
Thyroglobulin
HER2
Mammogram and tomosynthesis - BREAST
Osteocalcin
N-telopeptide, cross-linked
Computed tomography (CT) - PANCREAS
Magnetic resonance imaging (MRI) - GENITOURINARY
Ultrasound - BREAST
Dehydroepiandrosterone sulfate (DHEA-S)
Gastrin
Thyroid therapy - THYROID
Protein, total
Thyroid uptake and scan - THYROID
Follicle-stimulating hormone
Magnetic resonance imaging (MRI) - ABDOMEN
Thyroglobulin antibody
Iron-binding capacity
USE OF TESTS IN DIAGNOSIS AND MANAGEMENT
Luteinizing hormone
Procollagen type I N-terminal propeptide (PINP)
Alanine aminotransferase
Aspartate aminotransferase
Upper GI study (UGI) - GASTROINTESTINAL
Computed tomography (CT) - CHEST
Familial adenomatous polyposis (FAP)
α1-Antitrypsin
Complement C3
Uridine diphosphoglucuronosyltransferase 1A1 (UGT 1A1) variants
Laryngitis
MTHFR mutation
Neurofibromatosis (NF): von Recklinghausen disease (NF1) and bilateral acoustic NF (NF2)
Vitamin D, 25-hydroxy
Alkaline phosphatase
Calcitonin
White blood cell count and differential
Parathyroid hormone-related protein
Immunoglobulins
Bacterial/septic arthritis
Lipase
Bacteremia of unknown source
Kappa and lambda free light chains with ratio
BCR/ABL mutation analysis
ODDS-LIKELIHOOD RATIOS
TEST CHARACTERISTICS
UNDERLYING ASSUMPTIONS
COMMONLY USED POINT-OF-CARE TESTS




